Digital Health Summit No. 8: Keynote lecture from Dr. Daniel Sonntag about „Artificial Intelligence“

Thu, 2018 / 06 / 07

About the author

Ihr Ansprechpartner Prof. Matthias P. Schönermark, M.D., Ph.D.

Prof. Matthias P. Schönermark, M.D., Ph.D.
Founder and Managing Director

Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18

E-Mail More Contact Info

In most of our daily routines artificial intelligence already plays a significant role. But how can artificial intelligence enhance the health care sector? This question will be addressed by Dr. Daniel Sonntag, Research Director and Research Associate, who will give us insights on the newest developments at the Digital Health Summit no. 8 at this year's CEBIT in Hanover, Germany.

Dr. Sonntag works for the German Research Center for Artificial Intelligence (DFKI). In the field of innovative software technologies, DFKI is the leading research institution in Germany. You can find DFKI's exhibition booth with the topic „30 years artificial intelligence for humans” in hall 27, stand F62 at the CEBIT. For more background information about the DFKI, please view the video #roadtoCEBIT: The World of Artificial Intelligence.

As editor-in-chief of the German Journal of Artificial Intelligence (KI) and editor-in-chief of the Springer book series Cognitive Technologies, Dr. Daniel Sonntag currently manages national and European projects from the Federal Ministry of Education and Research, the Federal Ministry of Economics and Energy and Horizon 2020. Dr. Daniel Sonntag received the German High Tech Champion Award in 2011 and the AAAI Recognition Award as well as the IAAI Deployed Application Award in 2013.

Learn more about artificial intelligence – join us when Dr. Daniel Sonntag holds his keynote at the CEBIT on the 13^thof June in hall 26 from 11:45 AM to 12:15 PM.

The Digital Health Summit No. 8 is being presented to you in co-operation with the Federation of German Industries (BDI) and SKC Beratungsgesellschaft at the CEBIT. Please find all details in our agenda.

BY Prof. Matthias P. Schönermark, M.D., Ph.D., managing director and Sandra Nördemann